CLINICAL_TRIALS
trial_result
· 2013-11-21
Clinical Trial Update: A Placebo-Controlled, Double-Blind Comparative Study of E2080 in Lennox-Gastaut Syndrome Patients (Study E2080-J081-304) [Phase 3]
Summary
Phase 3 placebo-controlled study of E2080 in Lennox-Gastaut Syndrome has completed with results posted in 2013.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eisai Limited | Conditions: Lennox-Gastaut Syndrome | Phase 3 | Status: COMPLETED | Results posted: 2013-11-21